Bruce Peacock Insider Profile
4 Followers
Bruce Peacock, Director at Ocular Therapeutix, holds 0.00 shares in Ocular Therapeutix (Ticker: OCUL), holds 8.89K shares in Windtree Therapeutics (Ticker: WINT), holds 0.00 shares in Dicerna Pharma (Ticker: DRNA).
Bruce Peacock's Trading History
| OCULOcular Therapeutix | Dec 07, 2020 | Director | Uninformative Buy | 127.18K | $0.00 | |
| WINTWindtree Therapeutics | May 27, 2020 | Director | Informative Buy | 25.38K | $106.63 | |
| ISEEIVERIC bio | Sep 04, 2014 | ― | Uninformative Sell | 233.63K | $0.00 | |
| OPTTOcean Power Technologies | ― | Director | ― | $0.00 | ||
| NGSXNeurogesx | ― | ― | ― | $0.00 | ||
| LGNDLigand Pharma | ― | Director | ― | $6.12M | ||
| AGTCApplied Genetic Technologies | ― | ― | ― | $0.00 | ||
| DRNADicerna Pharma | ― | ― | ― | $0.00 |
You May Also Like
Bruce Peacock insider profile FAQ
What is the percentage of profitable transactions made by Bruce Peacock?
The percentage of profitable transactions made by Bruce Peacock is 80%.
What is the average return per transaction made by Bruce Peacock?
The average return per transaction made by Bruce Peacock is 18.80%.
What stocks does Bruce Peacock hold?
Bruce Peacock holds: OCUL, WINT, DRNA, AGTC, ISEE, LGND, NGSX, OPTT stocks.
What was Bruce Peacock’s latest transaction?
Bruce Peacock’s latest transaction was an Uninformative Buy of $127.18K.
What was Bruce Peacock's most profitable transaction?
Bruce Peacock’s most profitable transaction was an Informative Sell of OCUL stock on December 7, 2020. The return on the trade was 66.70%.
What is Bruce Peacock's role in Ocular Therapeutix?
Bruce Peacock's role in Ocular Therapeutix is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
